The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

These differences do not appear to correlate ... thinking earlier in the development process. Divisions between research teams and their commercial counterparts still pervade the pharmaceutical world.

Talin is a protein that plays an important role in the immune system by activating integrins, receptors that help cells ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...